Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods.

Hammer, Hilde Berner; Pedersen, Sigve Lans; Jonsson, Maria K; Mathsson-Alm, Linda; Gehring, Isabel; Sexton, Joe; Haavardsholm, Espen A; Askling, Johan

Hammer, Hilde Berner; Pedersen, Sigve Lans; Jonsson, Maria K; Mathsson-Alm, Linda; Gehring, Isabel; Sexton, Joe; Haavardsholm, Espen A; Askling, Johan.

Afiliação

Hammer HB; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.
Pedersen SL; Faculty of Medicine, University of Oslo, Oslo, Norway.
Jonsson MK; Clinical Laboratory, Diakonhjemmet Hospital, Oslo, Norway.
Mathsson-Alm L; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
Gehring I; Department of Paediatrics, Haukeland University Hospital, Bergen, Norway.
Sexton J; Thermo Fisher Scientific, Uppsala, Sweden.
Haavardsholm EA; Thermo Fisher Scientific, Freiburg, Germany.
Askling J; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.

Scand J Clin Lab Invest ; 83(5): 330-335, 2023 09.

Article em En | MEDLINE | ID: mdl-37343245

Assuntos

Artrite Reumatoide; Complexo Antígeno L1 Leucocitário; Humanos; Pessoa de Meia-Idade; Biomarcadores; Artrite Reumatoide/diagnóstico; Inflamação; Proteína C-Reativa/metabolismo; Calgranulina B; Calgranulina A

Palavras-chave

Calprotectin; enzyme-linked immunosorbent assay; fluoroenzyme immunoassay; rheumatoid arthritis; ultrasound

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Complexo Antígeno L1 Leucocitário Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google